AU2001271801A1 - Compositions and methods for producing recombinant virions - Google Patents
Compositions and methods for producing recombinant virionsInfo
- Publication number
- AU2001271801A1 AU2001271801A1 AU2001271801A AU7180101A AU2001271801A1 AU 2001271801 A1 AU2001271801 A1 AU 2001271801A1 AU 2001271801 A AU2001271801 A AU 2001271801A AU 7180101 A AU7180101 A AU 7180101A AU 2001271801 A1 AU2001271801 A1 AU 2001271801A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- producing recombinant
- recombinant virions
- virions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36151—Methods of production or purification of viral material
- C12N2770/36152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09608730 | 2000-06-30 | ||
US09/608,730 | 2000-06-30 | ||
US09/608,730 US6423544B1 (en) | 1998-12-31 | 2000-06-30 | Compositions and methods for producing recombinant virions |
PCT/US2001/021160 WO2002002789A2 (en) | 2000-06-30 | 2001-07-02 | Compositions and methods for producing recombinant virions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001271801A1 true AU2001271801A1 (en) | 2002-01-14 |
Family
ID=24437745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001271801A Abandoned AU2001271801A1 (en) | 2000-06-30 | 2001-07-02 | Compositions and methods for producing recombinant virions |
Country Status (3)
Country | Link |
---|---|
US (1) | US6423544B1 (en) |
AU (1) | AU2001271801A1 (en) |
WO (1) | WO2002002789A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1448246B2 (en) | 2001-11-19 | 2015-09-09 | Scil Technology GmbH | Method for producing a homogeneously coated device having osteoinductive and osteoconductive properties |
US20050251872A1 (en) * | 2002-09-06 | 2005-11-10 | Bear James E | Lentiviral vectors, related reagents, and methods of use thereof |
PL207552B1 (en) * | 2002-09-10 | 2010-12-31 | Scil Technology Gmbh | Metal implant coated under reduced oxygen concentration with osteoinductive protein |
KR100678223B1 (en) | 2003-03-13 | 2007-02-01 | 삼성전자주식회사 | Method and apparatus for packet transmitting in a communication system |
DK2691530T3 (en) | 2011-06-10 | 2018-05-22 | Univ Oregon Health & Science | CMV GLYCOPROTEIN AND RECOMBINANT VECTORS |
CN115998876B (en) * | 2022-12-21 | 2024-04-05 | 重庆医科大学 | Application of SAC1 as hepatitis B treatment target |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792462A (en) | 1995-05-23 | 1998-08-11 | University Of North Carolina At Chapel Hill | Alphavirus RNA replicon systems |
ATE386811T1 (en) | 1996-04-05 | 2008-03-15 | Novartis Vaccines & Diagnostic | ALPHAVIRUS VECTOR WITH A REDUCED INHIBITION OF THE SYNTHESIS OF CELL MACROMOLECLES |
US6180391B1 (en) * | 1998-01-28 | 2001-01-30 | Amgen Inc. | Highly efficient controlled expression of exogenous genes in e. coli |
KR20010079671A (en) * | 1998-08-20 | 2001-08-22 | 스티븐 에이. 서윈. 엠.디. | USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS |
WO2000020040A1 (en) * | 1998-10-08 | 2000-04-13 | University Of Massachusetts | Controlling gene expression in living cells |
CA2359013C (en) * | 1998-12-31 | 2011-02-01 | Chiron Corporation | Compositions and methods for packaging of alphavirus vectors |
US20030170871A1 (en) * | 2000-04-25 | 2003-09-11 | Chiron Corporation | Alphavirus-based vectors for persistent infection |
-
2000
- 2000-06-30 US US09/608,730 patent/US6423544B1/en not_active Expired - Fee Related
-
2001
- 2001-07-02 AU AU2001271801A patent/AU2001271801A1/en not_active Abandoned
- 2001-07-02 WO PCT/US2001/021160 patent/WO2002002789A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US6423544B1 (en) | 2002-07-23 |
WO2002002789A3 (en) | 2002-07-18 |
WO2002002789A2 (en) | 2002-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001286233A1 (en) | Cement composition | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2001234105A1 (en) | Cement composition | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2001248742A1 (en) | Compositions for promoting sleep | |
AU2002227369A1 (en) | Methods for producing and purifying recombinant alpha-l-iduronidase | |
AU2001292864A1 (en) | Methods and compositions for modulating angiogenesis | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2001290239A1 (en) | Medicinal composition | |
AU2002300192A1 (en) | Microemulsion Aerosol Composition | |
AU2001241098A1 (en) | Composition | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2002354270A1 (en) | Composition for mouth | |
AU2001261737A1 (en) | Methods and compositions for promoting angiogenesis using monocytes | |
AU2002210433A1 (en) | Dental compositions | |
AU2001271801A1 (en) | Compositions and methods for producing recombinant virions | |
AU2756301A (en) | Compositions comprising genome segments and methods of using the same | |
AU2001275201A1 (en) | Acne-treating composition | |
AU2001287852A1 (en) | Composition | |
AU2001267541A1 (en) | Vaccine composition | |
AU2001235764A1 (en) | Compositions | |
AU2002211741A1 (en) | Surface modifying composition | |
AU2001223721A1 (en) | Dental compositions | |
AU2001287732A1 (en) | Copolycarbonate-based composition | |
AU2002350181A1 (en) | Compositions and methods for viral delivery |